Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Strong demand for capital increase
DGAP-News: Carl Zeiss Meditec AG / Key word(s): Capital Increase/Corporate Action Press Release
JENA, 22 March 2017 Carl Zeiss Meditec AG has successfully completed a cash capital increase from authorized capital. Gross proceeds amount to approximately EUR 317 million. The capital increase announced yesterday has been successfully completed. The order book was closed early thanks to the strong demand. A total of 8,130,960 new shares were placed at a price of EUR 38.94 per share. The Company plans to use the funds raised to drive forward its growth strategy, especially through acquisitions. Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, comments on the successful conclusion of the capital increase: “We are delighted with the very strong demand for our new shares. The realised proceeds will provide us with the necessary firepower and flexibility to selectively exploit opportunities in our markets and to sustainably accelerate our growth. We would like to thank our new and existing shareholders for the high level of trust.” Joh. Berenberg, Gossler & Co. KG and Commerzbank AG are acting as Joint Global Coordinators and Joint Bookrunners for the transaction. The first trading day of the new shares is scheduled for 27 March 2017. Contact for media and investors www.zeiss.de/presse Notice Brief profile The Group’s head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company’s presence in these rapidly developing economies. Around 35 percent of Carl Zeiss Meditec AG’s shares are in free float. The remaining approx. 65 percent are held by Carl Zeiss AG, one of the world’s leading companies in the optical and optoelectronic industries. For more information visit our website at: www.zeiss.de
22.03.2017 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG. |
Language: | English |
Company: | Carl Zeiss Meditec AG |
Göschwitzer Str. 51-52 | |
07745 Jena | |
Germany | |
Phone: | +49 (0)3641 220-0 |
Fax: | +49 (0)3641 220-112 |
E-mail: | investors.meditec@zeiss.com |
Internet: | www.meditec.zeiss.de |
ISIN: | DE0005313704 |
WKN: | 531370 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
End of News | DGAP News Service |